New drug combo could boost breast cancer treatment before surgery

NCT ID NCT04335669

Ongoing Disease control Sponsor: Lund University Hospital Source: ClinicalTrials.gov ↗

Summary

This study is testing whether adding the drug capecitabine to standard carboplatin-based chemotherapy works better for treating early triple-negative breast cancer before surgery. Researchers want to see if this combination helps more patients achieve a complete response, meaning no detectable cancer remains after treatment. The trial involves 325 patients and is in its final testing phase to determine effectiveness and safety.

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Contacts and locations

Show contact details

Locations

Aalborg Universitetshospita

Aalborg, 9000, Denmark
Academical Hospital, Department of Oncology

Uppsala, 753 09, Sweden
Capio S:t Göran Hospital, Department of Oncology

Stockholm, 112 19, Sweden
Centralsjukhuset i Kristianstad

Kristianstad, Skåne County, 291 85, Sweden
Gävle hospital, Department of Oncology

Gävle, 803 24, Sweden
Halmstad Hospital, Department of Surgery

Halmstad, 302 33, Sweden
Karlstad Hospital

Karlstad, 652 30, Sweden
Nordsjællands Hospital

Hillerød, 3400, Denmark
Norrland University Hospital, Department of Oncology

Umeå, 907 37, Sweden
Regionsjælland Næstved Sygehus

Næstved, 4700, Denmark
Rigshospitalet

Copenhagen, 2100, Denmark
Ryhov Hospital

Jönköping, 551 85, Sweden
Sahlgrenska University Hospital, Department of Oncology

Gothenburg, 413 46, Sweden
Skåne University Hospital, Department of Oncology

Malmo, 20501, Sweden
Sundsvall hospital

Sundsvall, 851 86, Sweden
Sydvestjysk Sygehus

Esbjerg, 6700, Denmark
Södersjukhuset, Department of Oncology

Stockholm, 118 61, Sweden
Södra Älvsborgs Hospital

Borås, 501 82, Sweden
Sønderborg sygehus

Sønderborg, 6300, Denmark
Vejle Hospital

Vejle, Region Syd, 7100, Denmark
Vejle syghus

Vejle, 7100, Denmark
Västmanlands Hopsital Västerås

Västerås, 721 89, Sweden
Växjö Hospital, Department of Oncology

Vaxjo, 352 34, Sweden
Örebro University Hospital, Department of Oncology

Örebro, 701 85, Sweden

Conditions

Explore the condition pages connected to this study.

BREAST CANCER TRIPLE NEGATIVE BREAST NEOPLASMS